We need incentives for compassionate use in rare diseases

As the grandfather of a girl with a rare disease, I’ve learned that for families like ours, hope often comes not as a cure, but as a clinical trial: carefully designed but inevitably exclusive. My granddaughter Anna has Dravet syndrome, a catastrophic childhood epilepsy most often caused by mutations in the SCN1A gene. Like many … [Read more…]

Biological vs legal motherhood in surrogacy – a supportive guide for intended parents to be

If you’ve spent even five minutes researching surrogacy as a family building option, you’ll already have a pretty solid grasp of how the process works today. What can sometimes be less clear is the language. Terms are often used loosely or interchangeably online, which might stop you in your tracks, especially when you’re trying to … [Read more…]

Opinion: STAT+: If you have Alzheimer’s disease, who will take part in your care?

A reader — I’ll call him Jack — recently asked my thoughts on his plans to pursue treatment with lecanemab for his mild cognitive impairment caused by Alzheimer’s disease. So we set up a call to discuss what it is like to live beset by the threat of Alzheimer’s disease, but also the promise of … [Read more…]

No sperm in the sample? Obstructive vs non-obstructive azoospermia, misdiagnosis & new-gen treatment

Hearing that a semen analysis showed zero sperm can completely stop you in your tracks. This is what happened almost 10 years ago when TRB Founder Eloise Edington and her husband got his results back. For them, questions immediately began to spiral quickly: Can azoospermia be misdiagnosed? How do we know if it’s obstructive vs … [Read more…]

FDA will take action against Hims & Hers over compounded Wegovy

The Department of Health and Human Services asked the Department of Justice to investigate Hims & Hers for potentially violating federal law over its plan to make a compounded version of a low-cost weight loss pill widely available on its telehealth platform, according to a social media post by HHS general counsel Mike Stuart. The … [Read more…]

Gestational diabetes was a big part of Meghan Trainor’s weight loss – but you have questions

Grammy-winning singer Meghan Trainor has openly shared that a gestational diabetes diagnosis while she was pregnant helped shift her focus toward her long-term health and lifestyle, sparking a weight loss journey that saw her drop about 60 pounds. A fresh focus, and it includes Mounjaro In interviews reflecting on her journey, Meghan Trainor explained that … [Read more…]

Who does TrumpRx actually benefit?

The Trump administration is preparing to launch TrumpRx.com, an initiative aimed at lowering drug costs by aggregating direct-to-consumer access to branded prescription medications at discounted cash prices. The promise is seductive: lower prices on brand-name medications, available to anyone willing to bypass their insurance and pay out of pocket. But for most Americans, this initiative … [Read more…]

The impact of fires on fertility

Exposure to industrial gases and petroleum-derived particles can compromise reproductive health in the short and long term. Experts at Instituto Bernabeu point out that the endocrine disruptors present in smoke alter hormonal balance and semen quality. Following the fire at the distillation unit in Valle de Escombreras (Cartagena, Murcia), public concern has shifted from the … [Read more…]

Yes, but which? The best CoQ10 for fertility, heart health & key life stages

With decades of research behind it, Take Ubiquinol® is the go-to form of CoQ10 used by practitioners, found in over 200 trusted supplement brands and relied on by people (like me!) juggling fertility goals, an ‘in the thick of it’ lifestyle and perimenopause. It’s the bioactive, highly absorbable form of CoQ10 that your body can … [Read more…]

EPA value of life policy betrays a century of public health victories

What is the value of a human life? According to the Trump administration’s Environmental Protection Agency, the answer is zero dollars. Recently, in a decision buried in regulatory documents, the EPA announced it would no longer calculate the economic benefits of lives saved when setting limits on fine particulate matter and ozone, arguably two of … [Read more…]